Literature DB >> 23673890

Integrating behavioral and biomedical research in HIV interventions: challenges and opportunities.

Dianne M Rausch1, Cynthia I Grossman, Emily J Erbelding.   

Abstract

Recent clinical trials have demonstrated overwhelming success of biomedical tools to prevent the spread of HIV infection. However, the complex and somewhat disparate results of some of these trials have highlighted the need for effective integration of biomedical and behavioral sciences in the design and implementation of any future intervention trial. Integrating behavioral and biomedical sciences will require appropriate behavioral theories that can be used in the context of biomedical clinical trials and multidisciplinary teams working together from the earliest stages of trial design through to completion. It is also clear that integration of behavioral science will be necessary to implement prevention at the population level and reverse the HIV epidemic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673890     DOI: 10.1097/QAI.0b013e318292153b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.

Authors:  Emily A Krogstad; Elizabeth T Montgomery; Millicent Atujuna; Alexandra M Minnis; Shannon O'Rourke; Khatija Ahmed; Linda-Gail Bekker; Ariane van der Straten
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

Review 2.  Design Considerations for Implementing eHealth Behavioral Interventions for HIV Prevention in Evolving Sociotechnical Landscapes.

Authors:  Dennis H Li; C Hendricks Brown; Carlos Gallo; Ethan Morgan; Patrick S Sullivan; Sean D Young; Brian Mustanski
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

3.  Turning the tide in HIV through health communication research.

Authors:  Collene Lawhorn; Michael J Stirratt; Dianne M Rausch
Journal:  J Int AIDS Soc       Date:  2022-06       Impact factor: 6.707

4.  Human immunodeficiency virus and liver disease: An update.

Authors:  Kenneth E Sherman; Juergen Rockstroh; David Thomas
Journal:  Hepatology       Date:  2015-10-20       Impact factor: 17.425

5.  Economic Evaluation of Community-Based HIV Prevention Programs in Ontario: Evidence of Effectiveness in Reducing HIV Infections and Health Care Costs.

Authors:  Stephanie K Y Choi; David R Holtgrave; Jean Bacon; Rick Kennedy; Joanne Lush; Frank McGee; George A Tomlinson; Sean B Rourke
Journal:  AIDS Behav       Date:  2016-06

6.  Perspectives of South African youth in the development of an implant for HIV prevention.

Authors:  Emily A Krogstad; Millicent Atujuna; Elizabeth T Montgomery; Alexandra Minnis; Sheily Ndwayana; Tsholofelo Malapane; Mary Kate Shapley-Quinn; Kgahlisho Manenzhe; Linda-Gail Bekker; Ariane van der Straten
Journal:  J Int AIDS Soc       Date:  2018-08       Impact factor: 5.396

7.  Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning.

Authors:  Amy H Lin; Tiffany L Breger; Matthew Barnhart; Ann Kim; Charlotte Vangsgaard; Emily Harris
Journal:  J Int AIDS Soc       Date:  2014-09-08       Impact factor: 5.396

8.  Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples.

Authors:  Omar Martinez; Elwin Wu; Ethan C Levine; Miguel Muñoz-Laboy; M Isabel Fernandez; Sarah Bauerle Bass; Eva M Moya; Timothy Frasca; Silvia Chavez-Baray; Larry D Icard; Hugo Ovejero; Alex Carballo-Diéguez; Scott D Rhodes
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

9.  HIV psychiatry in the era of combined antiretroviral therapy: top five issues.

Authors:  Jorge L Zirulnik; Héctor M Perez
Journal:  J Int AIDS Soc       Date:  2015-11-06       Impact factor: 5.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.